Bcl-2 in Cell-Cycle Regulation of Hematopoietic Cells by Transforming Growth Factor-β1

References

• Lajhtha L. G. Stem cell concepts. Diffrerentiation 1979; 14: 23–34
   PubMed Web of Science ®Google Scholar
• Ogawa M. Differentiation and proliferation of hematopoietic stem cells. Blood 1993; 81: 2834–1853
   Web of Science ®Google Scholar
• Katayama N., Clark S. C., Ogawa M. Growth factor requirement for survival in cell-cycle dormancy of primitive lymphohematopoietic progenitors. Blood 1993; 81: 610–616
   PubMed Web of Science ®Google Scholar
• Itoh R., Katayama N., Kato T., Mahmud N., Masuya M., Ohishi K., Minami N., Miyazaki H., Shiku H. Activity of the ligand for c-mpl, thrombopoietin, in early haemopoiesis. British Journal of Haematology 1996; 94: 228–235
   PubMed Web of Science ®Google Scholar
• Tanaka R., Katayama N., Ohishi K., Mahmud N., Itoh K., Tanaka Y., Komada Y., Minami N., Sakurai M., Shirakawa S., Shiku H. Accelerated cell-cycling of hematopoietic progenitor cells by growth factors. Blood 1995; 86: 73–79
   PubMed Web of Science ®Google Scholar
• Ohishi K., Katayama N., Itoh R., Mahmud N., Miwa H., Kita K., Minami N., Shirakawa S., Lyman S. D., Shiku H. Accelerated cell-cycling of hematopoietic progenitors by the flt3 ligand that is modulated by transforming growth factor-β. Blood 1996; 87: 1718–1727
   PubMed Web of Science ®Google Scholar
• Mahmud N., Katayama N., Itoh R., Ohishi K., Masuya M., Minami N., Shiku H. G-CSF accelerates the cell-cycling of hematopoietic progenitor cells and abrogates the deceleration by TNFβ. International Journal of Oncology 1996; 8: 453–459
   PubMed Web of Science ®Google Scholar
• Massague J. A. The transforming growth factor-β family. Annual Review of Cell Biology 1990; 6: 597–641
   PubMedGoogle Scholar
• Sporn M. B., Roberts A. B. Transforming growth factor-β: recent progress and new challenges. Journal of Cell Biology 1992; 119: 1017–1021
   PubMed Web of Science ®Google Scholar
• Keller J. R., Mantel C., Sing G. K., Ellingsworth L. K., Ruscetti S. K., Ruscetti F. W. Transforming growth factor β1 selectively regulates early murine hematopoietic progenitors and inhibits the growth of IL-3-dependemt myeloid leukemia cell lines. Journal of Experimental Medicine 1988; 168: 737–750
   PubMed Web of Science ®Google Scholar
• Sing G. K., Keller J. R., Ellingsworth L. R., Ruscetti F. W. Transforming growth factor β selectively inhibits normal and leukemic human bone marrow cell growth in vitro. Blood 1988; 88: 1504–1511
   Google Scholar
• Cashman J. D., Eaves A. C., Raines E. W., Ross R., Eaves C. J. Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. I. Stimulatory role of a variety of mesenchymal cell activators and inhibitory role of TGF-β. Blood 1990; 75: 96–101
   PubMed Web of Science ®Google Scholar
• Hatzfeld J., Lin M.-L., Brown E. L., Sookdeo H., Levesque J.-P., O'Toole T., Gurney C., Clark S. C., Hatzfeld A. Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor β or Rb oligonucleotides. Journal of Experimental Medicine 1991; 174: 925–929
   PubMed Web of Science ®Google Scholar
• Ploemacher R. E., van Soest P. L., Boudewijn A. Autocrine transforming growth factor β1 blocks colony formation and progenitor cell generation by hematopoietic stem cells stimulated with steel factor. Stem Cells 1993; 11: 336–347
   PubMed Web of Science ®Google Scholar
• Sherr C. J. Mammalian G1 cyclins. Cell 1993; 73: 1059–1065
   PubMed Web of Science ®Google Scholar
• Hunter T. Braking the cycle. Cells 1993; 75: 839–841
   PubMed Web of Science ®Google Scholar
• Jacks T., Weinberg R. A. Cell-cycle control and its watchman. Science 1996; 381: 643–644
   Google Scholar
• Sherr C. J., Roberts J. M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes A Development 1995; 9: 1149–1163
   PubMed Web of Science ®Google Scholar
• Peter M., Herskowitz I. Joining the complex cyclin-dependent kinase inhibitory proteins and the cell cycle. Cell 1994; 79: 181–184
   PubMed Web of Science ®Google Scholar
• Polyak K., Lee M.-H., Erdjument-Bromage H., Koff A., Roberts J. M., Tempst P., Massague J. Cloning ofp27kipl a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 1904; 78: 50–66
   Google Scholar
• Toyoshima H., Hunter T. p27. a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 1994; 78: 67–74
   PubMed Web of Science ®Google Scholar
• Polyak K., Kato J. Y., Solomon M. J., Sherr C. J., Massague J., Roberts J. M., Koff A. p27-kipl. a cyclin-Cdk inhibitor. links transforming growth factor-β and contact inhibition to cell cycle arrest. Gene & Development 1994; 8: 9–22
   PubMed Web of Science ®Google Scholar
• Ewen M. E., Sluss H. K., Whitehouse I. L., Livingston D. M. TGF-β inhibition of edk4 synthesis is linked to cell cycle arrest. Cell 1993; 74: 1009–1020
   PubMed Web of Science ®Google Scholar
• Hannon G. J., Beach D. P15INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 1994; 371: 157–261
   Web of Science ®Google Scholar
• Campos L., Sabido O., Rouault J.-P., Guyota D. Effects of RCL-2 antisense' oligodeoxynucleotides on in vitro proliferation and survival of normal progenitors and leukemic cells. Blood 1994; 85: 595–600
   Google Scholar
• Motoyama N., Wang F., Roth K. A., Sawa H., Nakayama K.-I., Nakayama K., Negishi I., Senju S., Zhang Q., Fujii S., Loh D. Y. Massive cell death of immature hematopoietic cells and neurons in Bel-x-deficient mice. Science 1995; 267: 1506–1510
   PubMed Web of Science ®Google Scholar
• Park J. K., Bernstein I. D., Hockenbery D. M. Primitive human hematopoietic precursors express Bel-x but not Bel-2. Blood 1995; 86: 868–876
   PubMed Web of Science ®Google Scholar
• Bárcena A., Park S. W., Banapour B., Muench M. O., Mechetner E. Expression of Fas/CD95 and bel-2 by primitive hematopoietic progenitors freshly isolated from human fetal liver. Blood 1996; 88: 2013–2025
   PubMed Web of Science ®Google Scholar
• Weber-Nordt R. M., Henschter R., Schott E., Wehinger J., Behringer D., Mertelsmann R., Finke J. Inter-leukin-10 increases Bel-2 expression mid survival in primary human CD34* hematopoietic progenitor cells. Blood 1996; 88: 2549–2558
   PubMed Web of Science ®Google Scholar
• Sanz C., Benito A., Silva M., Albella B., Richard C., Insunza J. C., Segovia A., Bueren J. A., Fernández-Luna J. L. The expression of Bel-x IS downregulated during differentiation of human hematopoietic progenitor cells along the granulocytic but not the monoeyte/macrophage lineage. Blood 1997; 89: 3199–3204
   PubMed Web of Science ®Google Scholar
• Lisovsly M., Estrov Z., Zang X., Consoli U., Sanchez Williams G., Snell V., Munker R., Goodacre A., Savehenko V., Andreeff M. Flt3 ligand stimulates proliferation and inhibits apoptosis of acute myeloid leukemia cells: Regulation of Bel-2 and Bax. Blood 1996; 88: 3987–3997
   PubMed Web of Science ®Google Scholar
• Mazel S., Burtrum D., Petrie H. T. Regulation of cell division cycle progression by bel-2exprexsitin: A potential mechanism for inhibition of programmed cell death. Journal of Experimental Medicine 1996; 183: 2219–2226
   PubMed Web of Science ®Google Scholar
• Linette G. P., Li Y., Roth K., Korsmeyer S. J. Cross talk between cell death and cell cycle progression: BCL-2, regulates NFAT-mediated activation. Proceedings of the National Academy Science of the United States of America 1996; 93: 9545–9552
   PubMed Web of Science ®Google Scholar
• O'Reilly I. A., Huang D. C.S., Strasser A. The cell death inhibitor Bel-2 and its homologues influence control of cell-cycle entry. EMBO Journal 1996; 15: 6979–6990
   PubMed Web of Science ®Google Scholar
• Brady H. J.M., Gil-Gómez G., Kirberg J., Berns A. J.M. Baxα perturbs T cell development and affects cell cycle entry of T cells. EMBO Journal 1996; 15: 6991–7001
   PubMed Web of Science ®Google Scholar
• Mahmud N., Katayama N., Nhisbii K., Sugawara T., Komada Y., Mitani H., Araki H., Ohiahi K., Watanabe M., Masuya M., Nishikawa M., Minami N., Ohashi H., Shiku H., Shiku H. Possible involvement of bel-2. in regulation of cell-cycle progressions of haemopoietic cells by transforming growth factor β1. British Journal of Haematology 1909; 105: 470–477
   Google Scholar
• Kinoshita T., Yokota T., Arai K.-I., Miyajimia A. Regulation of Bel-2 expression by oncogenic Ras protein in hematopoietic cells. Oncogene 1995; 10: 2207–2212
   PubMed Web of Science ®Google Scholar
• Galli S. J., Zseho K. M., Geissler E. N. The e-kit ligand. stem cell factor. Advances in Immunology 1994; 55: 1–96
   PubMed Web of Science ®Google Scholar
• Ploemacher R. E., van Soest P. L., Boudewijn S. A. Autocrine transforming growth factor β1 blocks colony formation and progenitor cell generation by hematopoietic stem cells stimulated with steel factor. Stem Cells. 1993; 11: 336–347
   PubMed Web of Science ®Google Scholar
• Gil-Gómez G., Berns A., Brady H. J.M. A link between cell cycle and cell death: Bas and Bel-2 modulate Cdk2 activation during thymocyte apoptosis. EMBO Journal 1998; 17: 7209–7218
   PubMed Web of Science ®Google Scholar
• Hakem A., Sasaki T., Kozieradzki I., Penninger J. M. The cyclin-dependent kinase Cdk2 regulates thymocyte apoptosis. Journal of Experimental Medicine 1999; 189: 957–967
   PubMed Web of Science ®Google Scholar